Guobang Pharma Statistics

Total Valuation

Guobang Pharma has a market cap or net worth of CNY 14.48 billion. The enterprise value is 13.23 billion.

Market Cap	14.48B
Enterprise Value	13.23B

Important Dates

The next confirmed earnings date is Saturday, March 28, 2026.

Earnings Date	Mar 28, 2026
Ex-Dividend Date	Jun 13, 2025

Share Statistics

Guobang Pharma has 552.99 million shares outstanding. The number of shares has decreased by -0.21% in one year.

Current Share Class	552.99M
Shares Outstanding	552.99M
Shares Change (YoY)	-0.21%
Shares Change (QoQ)	+0.95%
Owned by Insiders (%)	12.79%
Owned by Institutions (%)	13.35%
Float	225.70M

Valuation Ratios

The trailing PE ratio is 16.68.

PE Ratio	16.68
Forward PE	n/a
PS Ratio	2.44
PB Ratio	1.75
P/TBV Ratio	1.83
P/FCF Ratio	24.25
P/OCF Ratio	13.42
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.40, with an EV/FCF ratio of 22.16.

EV / Earnings	15.16
EV / Sales	2.23
EV / EBITDA	9.40
EV / EBIT	14.85
EV / FCF	22.16

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.12.

Current Ratio	3.20
Quick Ratio	2.03
Debt / Equity	0.12
Debt / EBITDA	0.68
Debt / FCF	1.60
Interest Coverage	39.25

Financial Efficiency

Return on equity (ROE) is 10.79% and return on invested capital (ROIC) is 11.23%.

Return on Equity (ROE)	10.79%
Return on Assets (ROA)	5.25%
Return on Invested Capital (ROIC)	11.23%
Return on Capital Employed (ROCE)	10.14%
Weighted Average Cost of Capital (WACC)	6.13%
Revenue Per Employee	1.48M
Profits Per Employee	218,075
Employee Count	4,003
Asset Turnover	0.56
Inventory Turnover	3.04

Taxes

In the past 12 months, Guobang Pharma has paid 128.39 million in taxes.

Income Tax	128.39M
Effective Tax Rate	12.86%

Stock Price Statistics

The stock price has increased by +36.98% in the last 52 weeks. The beta is 0.39, so Guobang Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	+36.98%
50-Day Moving Average	26.04
200-Day Moving Average	23.09
Relative Strength Index (RSI)	41.55
Average Volume (20 Days)	3,806,943

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Guobang Pharma had revenue of CNY 5.94 billion and earned 872.95 million in profits. Earnings per share was 1.57.

Revenue	5.94B
Gross Profit	1.48B
Operating Income	890.91M
Pretax Income	998.22M
Net Income	872.95M
EBITDA	1.41B
EBIT	890.91M
Earnings Per Share (EPS)	1.57

Full Income Statement

Balance Sheet

The company has 2.21 billion in cash and 958.11 million in debt, giving a net cash position of 1.25 billion or 2.26 per share.

Cash & Cash Equivalents	2.21B
Total Debt	958.11M
Net Cash	1.25B
Net Cash Per Share	2.26
Equity (Book Value)	8.28B
Book Value Per Share	15.02
Working Capital	3.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.08 billion and capital expenditures -481.97 million, giving a free cash flow of 597.08 million.

Operating Cash Flow	1.08B
Capital Expenditures	-481.97M
Free Cash Flow	597.08M
FCF Per Share	1.08

Full Cash Flow Statement

Margins

Gross margin is 24.93%, with operating and profit margins of 14.99% and 14.69%.

Gross Margin	24.93%
Operating Margin	14.99%
Pretax Margin	16.80%
Profit Margin	14.69%
EBITDA Margin	23.69%
EBIT Margin	14.99%
FCF Margin	10.05%

Dividends & Yields

This stock pays an annual dividend of 0.61, which amounts to a dividend yield of 2.27%.

Dividend Per Share	0.61
Dividend Yield	2.27%
Dividend Growth (YoY)	100.92%
Years of Dividend Growth	1
Payout Ratio	40.77%
Buyback Yield	0.21%
Shareholder Yield	2.48%
Earnings Yield	6.03%
FCF Yield	4.12%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guobang Pharma has an Altman Z-Score of 4.84 and a Piotroski F-Score of 7.

Altman Z-Score	4.84
Piotroski F-Score	7